Clinical Trial Update: Semaglutide for Smoking Cessation in Patients With Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating semaglutide for smoking cessation in adults with type 2 diabetes; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Diabetes Mellitus, Type 2, Nicotine Addiction | Phase 3 | Status: NOT_YET_RECRUITING